Literature DB >> 18658050

Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity.

Viviane Zorzanelli Rocha1, Eduardo J Folco, Galina Sukhova, Koichi Shimizu, Israel Gotsman, Ashley H Vernon, Peter Libby.   

Abstract

Adipose tissue (AT) can accumulate macrophages and secrete several inflammatory mediators. Despite its pivotal role in the progression of chronic inflammatory processes such as atherosclerosis, the adaptive role of immunity in obesity remains poorly explored. Visceral AT of diet-induced obese C57BL/6 mice had higher numbers of both CD4(+) and CD8(+) T cells than lean controls, monitored by flow cytometry. When stimulated in vitro, T cells from obese AT produced more interferon (IFN)gamma than those from controls. AT from obese animals also had more cells expressing I-A(b), a mouse class II histocompatibility marker implicated in antigen presentation, as determined by immunostaining. Differentiated 3T3-L1 cells stimulated with recombinant IFNgamma or T-helper 1-derived supernatant produced several chemokines and their mRNAs. Obese IFNgamma-deficient animals had significantly reduced AT expression of mRNA-encoding inflammatory genes such as tumor necrosis factor-alpha and monocyte chemoattractant protein-1, decreased AT inflammatory cell accumulation, and better glucose tolerance than control animals consuming the same diet. Obese mice doubly deficient for IFNgamma receptor and apolipoprotein (Apo)E on a mixed 129SvEv/C57BL/6 (129/B6) genetic background, despite exhibiting similar AT mRNA levels of tumor necrosis factor-alpha and monocyte chemoattractant protein-1 as 129/B6-ApoE(-/-) controls, had decreased expression of important T cell-related genes, such as IFNgamma-inducible protein-10 and I-A(b), and lower plasma triglycerides and glucose. These results indicate a role for T cells and IFNgamma, a prototypical T-helper 1 cytokine, in regulation of the inflammatory response that accompanies obesity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18658050      PMCID: PMC2740384          DOI: 10.1161/CIRCRESAHA.108.177105

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  33 in total

1.  Effects of gamma-interferon on the endocrine system: results from a phase I study.

Authors:  D Goldstein; J Gockerman; R Krishnan; J Ritchie; C Y Tso; L E Hood; E Ellinwood; J Laszlo
Journal:  Cancer Res       Date:  1987-12-01       Impact factor: 12.701

Review 2.  The multiple facets of the fat tissue.

Authors:  Viviane Zorzanelli Rocha; Peter Libby
Journal:  Thyroid       Date:  2008-02       Impact factor: 6.568

3.  Interferon-gamma elicits arteriosclerosis in the absence of leukocytes.

Authors:  G Tellides; D A Tereb; N C Kirkiles-Smith; R W Kim; J H Wilson; J S Schechner; M I Lorber; J S Pober
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

4.  Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.

Authors:  Niels R Veillard; Brenda Kwak; Graziano Pelli; Flore Mulhaupt; Richard W James; Amanda E I Proudfoot; François Mach
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

5.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

Authors:  Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

6.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

Authors:  Haiyan Xu; Glenn T Barnes; Qing Yang; Guo Tan; Daseng Yang; Chieh J Chou; Jason Sole; Andrew Nichols; Jeffrey S Ross; Louis A Tartaglia; Hong Chen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

7.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro.

Authors:  G K Hansson; L Jonasson; J Holm; M M Clowes; A W Clowes
Journal:  Circ Res       Date:  1988-10       Impact factor: 17.367

9.  Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis.

Authors:  K R Feingold; W Doerrler; C A Dinarello; W Fiers; C Grunfeld
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

10.  Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.

Authors:  J S Patton; H M Shepard; H Wilking; G Lewis; B B Aggarwal; T E Eessalu; L A Gavin; C Grunfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  233 in total

Review 1.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Adipocyte dysfunction and hypertension.

Authors:  Junlan Zhou; Gangjian Qin
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

3.  A Western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generations.

Authors:  Florence Massiera; Pascal Barbry; Philippe Guesnet; Aurélie Joly; Serge Luquet; Chimène Moreilhon-Brest; Tala Mohsen-Kanson; Ez-Zoubir Amri; Gérard Ailhaud
Journal:  J Lipid Res       Date:  2010-04-20       Impact factor: 5.922

4.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

5.  Adipose tissue inflammation and reduced insulin sensitivity in ovariectomized mice occurs in the absence of increased adiposity.

Authors:  Victoria J Vieira Potter; Katherine J Strissel; Chen Xie; Eugene Chang; Grace Bennett; Jason Defuria; Martin S Obin; Andrew S Greenberg
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

6.  Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity.

Authors:  Nicole H Rogers; James W Perfield; Katherine J Strissel; Martin S Obin; Andrew S Greenberg
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

7.  Pyroglutamylated RF-amide peptide (QRFP) gene is regulated by metabolic endotoxemia.

Authors:  Christian Jossart; Mukandila Mulumba; Riccarda Granata; Davide Gallo; Ezio Ghigo; Sylvie Marleau; Marc J Servant; Huy Ong
Journal:  Mol Endocrinol       Date:  2013-01-01

8.  CXCR3 controls T-cell accumulation in fat inflammation.

Authors:  Viviane Zorzanelli Rocha; Eduardo J Folco; Cafer Ozdemir; Yuri Sheikine; Thomas Christen; Galina K Sukhova; Eva H C Tang; Marcio Sommer Bittencourt; Raul D Santos; Andrew D Luster; David E Cohen; Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-08       Impact factor: 8.311

9.  STAT1, NF-κB and ERKs play a role in the induction of lipocalin-2 expression in adipocytes.

Authors:  Peng Zhao; Jacqueline Marie Stephens
Journal:  Mol Metab       Date:  2013-05-09       Impact factor: 7.422

Review 10.  Adipose tissue inflammation in glucose metabolism.

Authors:  H L Kammoun; M J Kraakman; M A Febbraio
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.